No paralogue variants have been mapped to residue 98 for KCNJ2.
| KCNJ2 | YLADIFTTCVDIRWRWMLVIFCLAFVLSWL>F<FGCVFWLIALLHGDLDAS------------ | 116 |
| KCNJ1 | FFVDIWTTVLDLKWRYKMTIFITAFLGSWF>F<FGLLWYAVAYIHKDLPEF--HP-------- | 114 |
| KCNJ3 | YLSDLFTTLVDLKWRWNLFIFILTYTVAWL>F<MASMWWVIAYTRGDLNKA--HV-------- | 117 |
| KCNJ4 | YMADIFTTCVDTRWRYMLMIFSAAFLVSWL>F<FGLLFWCIAFFHGDLEAS--PGVPAAGGPA | 100 |
| KCNJ5 | YLSDLFTTLVDLKWRFNLLVFTMVYTVTWL>F<FGFIWWLIAYIRGDLDHV--GD-------- | 123 |
| KCNJ6 | YLTDIFTTLVDLKWRFNLLIFVMVYTVTWL>F<FGMIWWLIAYIRGDMDHI--ED-------- | 126 |
| KCNJ8 | FLQDIFTTLVDLKWRHTLVIFTMSFLCSWL>L<FAIMWWLVAFAHGDIYAY--MEKS--G--- | 109 |
| KCNJ9 | YLTDLFTTLVDLQWRLSLLFFVLAYALTWL>F<FGAIWWLIAYGRGDLEHL--ED-------- | 94 |
| KCNJ10 | YLKDLWTTFIDMQWRYKLLLFSATFAGTWF>L<FGVVWYLVAVAHGDLLEL--DP-------- | 101 |
| KCNJ11 | FLQDVFTTLVDLKWPHTLLIFTMSFLCSWL>L<FAMAWWLIAFAHGDLAP----S-E------ | 104 |
| KCNJ12 | YLADMFTTCVDIRWRYMLLIFSLAFLASWL>L<FGIIFWVIAVAHGDLEPA--EG-------- | 117 |
| KCNJ13 | YLRDAWGILMDMRWRWMMLVFSASFVVHWL>V<FAVLWYVLAEMNGDLELDHDAP-------- | 92 |
| KCNJ14 | YLSDLFTTCVDVRWRWMCLLFSCSFLASWL>L<FGLAFWLIASLHGDLAAP--P--------- | 122 |
| KCNJ15 | YLQDLWTTVIDMKWRYKLTLFAATFVMTWF>L<FGVIYYAIAFIHGDLEPG--EP-------- | 100 |
| KCNJ16 | YVVDIFTTLVDTKWRHMFVIFSLSYILSWL>I<FGSVFWLIAFHHGDLLND--P--------- | 106 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.F98V | c.292T>G | Putative Benign | rs79650811 | SIFT: tolerated Polyphen: benign |